<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="COI-statement">
 <title>Conflicts of Interest</title>
 <p>60P Pharmaceuticals; Eisai Co., Ltd.; Johnson &amp; Johnson; Merck KGaA; MSD; and Pfizer reviewed and approved the descriptions of their WIPO Re:Search collaborations for this article. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the article apart from those disclosed. </p>
</notes>
